Skip to main content
. 2014 Mar 2;2014:794078. doi: 10.1155/2014/794078

Table 2.

Rates of thrombotic events in the two groups with different duration of dual antiplatelet therapy.

Study ID Total number in short duration group Total number in longer duration group Stent thrombosis Myocardial infarction Stroke Revascularization Cerebrovascular
death
All-cause mortality Death and myocardial infarction
Short Long Short Long Short Long Short Long Short Long Short Long Short Long
Gwon et al. 2012 (EXCELLENT trial) [6] 722 721 6 (0.9%)
definite
0 (0%) probable
0 definite
1 (0.1%) probable
13
(1.8%)
7
(1%)
3 (0.4%) 5 (0.7%) Target lesion revascularization 17 (2.4%)
Target vessel revascularization 22 (3.1%)
Any 43 (6.2%)
Target lesion revascularization 18 (2.8%)
Target vessel revascularization 22 (3.2%)
Any 43 (6.2%)
2 
(0.3%)
3 
(0.4%)
4 
(0.6%)
7 
(1%)
17 
(2.4%)
14 
(1.9%)

Hu and Wang 2012 [10] 88 94 Incidence 0.2% definite or probable Incidence 0%
definite or probable
Incidence
0.2%
Incidence
1%
NA NA NA NA NA NA Incidence 2.6% Incidence 2.3% NA NA

Kim et al. 2012 (RESET trial) [7] 1,059 1,058 2 (0.2%)
definite or probable
3 (0.3%)
definite or probable
2
(0.2%)
4
(0.4%)
6 (0.6%) 6 (0.7%) Target vessel revascularization 31 (3.9%) Target vessel revascularization 27 (3.7%) 2 
(0.2%)
4 
(0.4%)
5 
(0.5%)
8 
(1%)
7 
(0.7%)
11 
(1.0%)

Park et al. 2010 (REAL-LATE and ZEST-LATE) [8] 1,344 1,357 4 definite (0.3%) 5 definite (0.4%) 7
(0.5%)
10
(0.7%)
4 (0.3%) 9 (0.7%) Any 26 (2.4%) Any 36 (3.1%) NA NA 13 
(10%)
20 
(15%)
17 
(1.3%)
27 
(2.0%)

Valgimigli et al. 2012 (PRODIGY) [9] 983 987 7 definite (0.7%), 15 definite or probable (1.5%),
46 definite or probable or possible (4.7%)
8 definite (0.8%), 13 definite or probable (1.3%), 38 definite or probable or possible (3.9%) 41
(4.2%)
39
(4%)
14 (1.4%) 21 (2.1%) NA NA 37 
(3.8%)
36 
(3.7%)
65 
(6.6%)
65 
(6.6%)
94 
(9.6%)
88 
(8.9%)